Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expression of HER2 in the eye and the potential for on-target side effects with antibody-drug conjugates.

Scientific reportsĀ·2026
Same author

Active Hexose Correlated Compound Modulates Gut Microbiota and Improves Intestinal Barrier Function in a High-Fat Diet-Induced NAFLD in Rats.

Molecular nutrition & food researchĀ·2025
Same author

Trio exome sequencing of an optic nerve hypoplasia cohort reveals evidence for polygenic architecture.

Ophthalmic geneticsĀ·2025
Same author

Identification and characterization of early human photoreceptor states and cell-state-specific retinoblastoma-related features.

eLifeĀ·2025
Same author

Chevreul: an R bioconductor package for exploratory analysis of full-length single cell sequencing.

GigaByte (Hong Kong, China)Ā·2025
Same author

Chevreul: An R Bioconductor Package for Exploratory Analysis of Full-Length Single Cell Sequencing.

bioRxiv : the preprint server for biologyĀ·2025

Related Experiment Video

Updated: Dec 27, 2025

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles
11:08

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles

Published on: April 8, 2012

36.0K

Improved third-generation lentiviral packaging with pLKO.1C vectors.

Sunhye Lee1,2, David Cobrinik1,2,3,4,5

  • 1The Vision Center, Children's Hospital Los Angeles, Los Angeles, CA 90027, USA.

Biotechniques
|March 7, 2020
PubMed
Summary

This study enhances lentiviral vector production by modifying the pLKO.1 vector with a Cytomegalovirus promoter and optimizing packaging constructs. This significantly increases lentiviral titers for improved gene knockdown applications.

Keywords:
lentiviruspLKO.1shRNAthird-generation viral packaging

More Related Videos

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
13:47

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

10.2K
Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System
08:46

Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System

Published on: May 24, 2012

36.7K

Related Experiment Videos

Last Updated: Dec 27, 2025

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles
11:08

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles

Published on: April 8, 2012

36.0K
Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
13:47

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

10.2K
Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System
08:46

Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System

Published on: May 24, 2012

36.7K

Area of Science:

  • Molecular Biology
  • Virology
  • Gene Therapy

Background:

  • Third-generation lentiviral packaging systems enhance biosafety by removing HIV accessory genes.
  • The pLKO.1 vector's safety features, particularly the absence of the tat gene, can reduce lentiviral titers.
  • Efficient lentiviral vector production is crucial for gene therapy and research applications.

Purpose of the Study:

  • To improve lentiviral vector production and target gene knockdown efficiency.
  • To overcome titer limitations associated with third-generation lentiviral packaging systems for the pLKO.1 vector.
  • To present a modified pLKO.1 vector and optimized packaging construct ratios for enhanced virus yield.

Main Methods:

  • Modification of the pLKO.1 vector by replacing the RSV promoter with the Cytomegalovirus (CMV) promoter.
  • Optimization of packaging construct ratios for lentiviral vector production.
  • Comparison of viral titers generated by the modified pLKO.1 vector against standard pLKO.1 using third-generation and second-generation systems.

Main Results:

  • The modified pLKO.1 CMV vector yielded an average of threefold higher lentiviral titer compared to standard pLKO.1 with third-generation packaging.
  • Further optimization of packaging vector ratios resulted in an average tenfold higher titer than standard pLKO.1 with second-generation packaging.
  • Enhanced titers suggest improved potential for target gene knockdown.

Conclusions:

  • A modified pLKO.1 vector utilizing a CMV promoter and optimized packaging ratios significantly enhances lentiviral production.
  • This approach offers a viable strategy to overcome titer limitations in third-generation lentiviral systems.
  • The improved lentiviral titers facilitate more effective gene knockdown in research and therapeutic applications.